Get started
Author

Vincenzo J. Pizzuti

Observed names: Pizzuti V, Pizzuti, Vincenzo J, Vincenzo J. Pizzuti, Vincenzo J. Pizzuti, Vincenzo J Pizzuti, Vincenzo Pizzuti
Observed institutions: University of Notre Dame, West Virginia University, Purdue University West Lafayette, Istituto Neurologico Mediterraneo, University of Colorado Cancer Center, University of Colorado Anschutz, Sapienza University of Rome
ORCID: 0000-0002-1708-3776
Observed ORCID: 0000-0002-1708-3776
OpenAlex ID: A5063638010
Dual Carfilzomib and Doxorubicin–Loaded Liposomal Nanoparticles for Synergistic Efficacy in Multiple Myeloma
2016 · Jonathan D. Ashley, Charissa J. Quinlan, et al. · Molecular Cancer Therapeutics · 75
Radioluminescent nanoparticles for radiation-controlled release of drugs
2019 · Rahul Misra, Kaustabh Sarkar, et al. · Journal of Controlled Release · 38
Bilirubin-Coated Radioluminescent Particles for Radiation-Induced Photodynamic Therapy
2020 · Vincenzo J. Pizzuti, Dhushyanth Viswanath, et al. · ACS Applied Bio Materials · 20
PEG–PLA-Coated and Uncoated Radio-Luminescent CaWO4 Micro- and Nanoparticles for Concomitant Radiation and UV-A/Radio-Enhancement Cancer Treatments
2018 · Sung Duk Jo, Jaewon Lee, et al. · ACS Biomaterials Science & Engineering · 20
Nanoallergens: A multivalent platform for studying and evaluating potency of allergen epitopes in cellular degranulation
2016 · Peter E Deak, Maura R Vrabel, et al. · Experimental Biology and Medicine · 19
Folic Acid-Conjugated Radioluminescent Calcium Tungstate Nanoparticles as Radio-Sensitizers for Cancer Radiotherapy
2019 · Vincenzo J. Pizzuti, Rahul Misra, et al. · ACS Biomaterials Science & Engineering · 16
Nanotechnology‐enhanced radiotherapy and the abscopal effect: Current status and challenges of nanomaterial‐based radio‐immunotherapy
2023 · Dhushyanth Viswanath, Jeehun Park, et al. · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · 12
An Overview of Nanotherapeutic Drug Delivery Options for the Management of Glioblastoma
2023 · William H. Pentz, Vincenzo J. Pizzuti, et al. · Journal of Nanotheranostics · 8
PDF
A Review of Mathematics Determining Solute Uptake at the Blood–Brain Barrier in Normal and Pathological Conditions
2021 · Samuel Sprowls, Pushkar Saralkar, et al. · Pharmaceutics · 4
PDF
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
2021 · Samuel A. Sprowls, Vincenzo J. Pizzuti, et al. · Journal of Visualized Experiments · 4
Pilot-Scale Optimization of the Solvent Exchange Production and Lyophilization Processing of PEG–PLA Block Copolymer-Encapsulated CaWO4 Radioluminescent Nanoparticles for Theranostic Applications
2021 · Anish P. Patel, Christopher R. Schorr, et al. · Industrial & Engineering Chemistry Research · 3
Real-world outcomes of frontline polatuzumab-rchp and impact of frailty in older adults with diffuse large B-cell lymphoma
2025 · Varun Iyengar, Jomel Meeko Manzano, et al. · Blood · 1
Modeling Longitudinal Quality of Life Changes in Patients Diagnosed with Lymphomas: Heatmap Analysis of Electronic Patient-Reported Outcomes (ePRO) Data from the Bison-PRO Quality of Life Study
2024 · Vincenzo J Pizzuti, Kaitlyn Hoover, et al. · Blood · 1
Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
2021 · Samuel A. Sprowls, Vincenzo J. Pizzuti, et al. · Journal of Visualized Experiments · 1
PDF
Radiation increases BTB permeability in a preclinical model of breast cancer brain metastasis.
2020 · Samuel Adam Sprowls, Tasneem A Arsiwala, et al. · 1
PDF
Second Line CD19 CAR-T vs Platinum Salvage and Autologous Stem Cell Transplant for Primary Mediastinal B-Cell Lymphoma
2026 · Xi Yang, Henry Dumke, et al. · Blood Advances
Longitudinal patient-reported outcomes and quality-of-life trajectories over 2 years in CAR-T therapy recipients
2026 · Vincenzo J. Pizzuti, Angela Dunn, et al. · Blood Neoplasia
PDF
Favorable Real-World Outcomes of Lisocabtagene Maraleucel in Chronic Lymphocytic Leukemia
2026 · Jennifer J. Huang, Jenna M Voutsinas, et al. · Transplantation and Cellular Therapy
POSTER: ABCL-817 Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): A Multicenter Study
2025 · Jessica Chicola, Jomel Meeko Manzano, et al. · Clinical Lymphoma Myeloma & Leukemia
ABCL-817: Real-World Outcomes of Frontline Polatuzumab and Impact of Frailty in Older Adults With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): A Multicenter Study
2025 · Jessica Chicola, Jomel Meeko Manzano, et al. · Clinical Lymphoma Myeloma & Leukemia
344. Evaluation and Comparison of the Complex Outpatient Oral Antibiotics Therapy (COPAT) Program vs Oral Parenteral Antibiotic Therapy (OPAT) Program at West Virginia University (WVU) Medicine Healthcare System
2023 · Ololade O Okunlola, Vincenzo J Pizzuti, et al. · Open Forum Infectious Diseases
PDF
Supporting Information from Dual Carfilzomib and Doxorubicin–Loaded Liposomal Nanoparticles for Synergistic Efficacy in Multiple Myeloma
2023 · Jonathan D. Ashley, Charissa J. Quinlan, et al.
Supporting Information from Dual Carfilzomib and Doxorubicin–Loaded Liposomal Nanoparticles for Synergistic Efficacy in Multiple Myeloma
2023 · Jonathan D. Ashley, Charissa J. Quinlan, et al.
Data from Dual Carfilzomib and Doxorubicin–Loaded Liposomal Nanoparticles for Synergistic Efficacy in Multiple Myeloma
2023 · Jonathan D. Ashley, Charissa J. Quinlan, et al.
Data from Dual Carfilzomib and Doxorubicin–Loaded Liposomal Nanoparticles for Synergistic Efficacy in Multiple Myeloma
2023 · Jonathan D. Ashley, Charissa J. Quinlan, et al.
Works count: 28
Citation count: 223
H-index: 8
I10-index: 7
Year
Topic
Type